Sugi Predict

Sugi Predict / Compounds / SCHEMBL4461933

SCHEMBL4461933

SCHEMBL4461933

O=[N+]([O-])c1ccc2cccnc2c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.65
▸ MAPT P10636 10/20 0.62
▸ ALDH1A1 P00352 9/20 0.62
▸ MEN1 O00255 7/20 0.62
▸ KMT2A Q03164 7/20 0.62
▸ KDM4E B2RXH2 7/20 0.62
▸ CTSB P07858 2/20 0.62
▸ IDO1 P14902 2/20 0.62
▸ TDO2 P48775 2/20 0.62
▸ GAA P10253 2/20 0.62
▸ HSP90AA1 P07900 4/20 0.60
▸ HSP90AB1 P08238 1/20 0.60
▸ TDP1 Q9NUW8 7/20 0.58
▸ SMN1; SMN2 Q16637 6/20 0.58
▸ LMNA P02545 5/20 0.58
▸ HTT P42858 5/20 0.58
▸ CASP6 P55212 3/20 0.58
▸ NPC1 O15118 3/20 0.58
▸ RAB9A P51151 3/20 0.58
▸ OPRK1 P41145 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30122552 1.00 PDE10A (0.65) PDE10AMAPTALDH1A1MEN1KMT2A
Benzoic Acid SCHEMBL4470216 0.89 ALDH1A1 (0.54) PDE10AMAPTALDH1A1MEN1KMT2A
Benzoic Acid SCHEMBL4470207 0.89 ALDH1A1 (0.54) PDE10AMAPTALDH1A1MEN1KMT2A
SCHEMBL4461914 0.87 ALDH1A1 (0.58) PDE10AMAPTALDH1A1MEN1KMT2A
4-Nitrobenzoic Acid SCHEMBL4454979 0.85 KDR (0.54) PDE10AMAPTALDH1A1MEN1KMT2A
Salicylic Acid SCHEMBL4456443 0.85 ALDH1A1 (0.64) PDE10AMAPTALDH1A1MEN1KMT2A
Salicylic Acid SCHEMBL4456438 0.85 ALDH1A1 (0.64) PDE10AMAPTALDH1A1MEN1KMT2A
4-Chloro-Benzoic Acid SCHEMBL4457911 0.84 ALDH1A1 (0.49) PDE10AMAPTALDH1A1MEN1KMT2A
SCHEMBL4462749 0.84 RCE1 (0.55) PDE10AMAPTALDH1A1MEN1KMT2A
SCHEMBL4459175 0.84 PDE4D (0.51) PDE10AMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 — — WO claimed
CN-120794909-A Nitroquinoline production process and application thereof 张涵 2025-10-17 — — CN disclosed
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 — — EP disclosed
CN-120035438-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2025-05-23 — — CN disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 — — US disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 — — US disclosed
WO-2024109684-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE 江苏亚虹医药科技股份有限公司 2024-05-30 — — WO disclosed
CN-118084771-A Ru-catalyzed method for synthesizing 3-methylpiperidine by cyclizing 1, 5-diamino-2-methylpentane 中国科学院兰州化学物理研究所 2024-05-28 — — CN disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 — — CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 — — EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 — — CN disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 — — WO disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 — — WO disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 — — WO disclosed
CN-109796411-B Method for preparing 4, 5-dinitroimidazole by using microchannel reactor 南京理工大学 2022-01-14 — — CN disclosed
CN-109627683-A A kind of gasket composite material and preparation method 衢州寰宇信息咨询有限公司 2019-04-16 — — CN disclosed
CN-101890018-B Tyrosine protein kinase inhibitor and preparation method thereof CHINESE ACAD INST CHEMISTRY 2014-06-18 — — CN disclosed
CN-101890018-A Tyrosine protein kinase inhibitor and preparation method thereof CHINESE ACAD INST CHEMISTRY 2010-11-24 — — CN disclosed
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 — — WO disclosed
US-5466392-A Organic electroluminescence device and compound having an aluminum complex structure IDEMITSU KOSAN CO., LTD. (JP) 1995-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 PDE10A 1554/4885MAPT 4416/4885ALDH1A1 1017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.